We are live on ! Find out more
MYOV

Myovant Sciences Ltd.

Delisted

MYOV was delisted on the 9th of March, 2023.

91 hedge funds and large institutions have $369M invested in Myovant Sciences Ltd. in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

2% more funds holding

Funds holding: 8991 (+2)

0% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 29

5% less call options, than puts

Call options by funds: $8.33M | Put options by funds: $8.73M

8% less capital invested

Capital invested by funds: $400M → $369M (-$30.7M)

Holders
91
Holders Change
+2
Holders Change %
+2.25%
% of All Funds
1.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
29
Reduced
29
Closed
13
Calls
$8.33M
Puts
$8.73M
Net Calls
-$400K
Net Calls Change
+$3M
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
101
Simplex Trading
Illinois
-$49.8K -4,510 Closed
Bessemer Group
102
Bessemer Group
New Jersey
-$4K -277 Closed
Kayne Anderson Rudnick Investment Management
103
Kayne Anderson Rudnick Investment Management
California
-$1K -97 Closed

MYOV Hedge Fund Activity: Q2 2022 in Review

91 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2022, worth a combined $369M — down 7.7% from $400M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new MYOV positions and 13 closed out — a net gain of 2 holders — while 29 added to existing stakes and 29 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $7M. The largest seller was State Street, cutting an estimated $12.2M.

  • 91 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2022, up from 89 in Q1 2022.
  • Funds reported $369M of Myovant Sciences Ltd. stock for Q2 2022, down 7.7% quarter-over-quarter.
  • 15 funds opened new Myovant Sciences Ltd. positions in Q2 2022 and 13 closed out, a net change of +2 holders.
  • The largest Myovant Sciences Ltd. buyer in Q2 2022 was Wellington Management Group, an estimated $7M added.
  • The largest Myovant Sciences Ltd. seller in Q2 2022 was State Street, an estimated $12.2M sold.

Based on aggregated 13F filings for Q2 2022.